Answers are grounded in this paper and cite their sources.
The LMQ version 3 (LMQ-3) instrument has acceptable construct, criterion-related and known-groups validity, and is internally consistent as a measure of medicine burden, although reliability requires further confirmation. It could be used to measure the outcome of interventions designed to reduce the burden of polypharmacy.
No takes yet. Share an insight, caveat, or question.
Katusiime et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: